Avanos Medical, Inc.
AVNS
$11.36
-$0.07-0.61%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 692.50M | 689.20M | 687.80M | 681.50M | 682.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 692.50M | 689.20M | 687.80M | 681.50M | 682.40M |
| Cost of Revenue | 319.70M | 312.90M | 306.50M | 303.20M | 301.50M |
| Gross Profit | 372.80M | 376.30M | 381.30M | 378.30M | 380.90M |
| SG&A Expenses | 325.00M | 322.40M | 329.30M | 318.10M | 322.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -600.00K | 1.20M | 3.00M | 2.70M | 4.30M |
| Total Operating Expenses | 654.40M | 647.30M | 651.20M | 636.70M | 639.50M |
| Operating Income | 38.10M | 41.90M | 36.60M | 44.80M | 42.90M |
| Income Before Tax | -477.20M | -395.10M | -403.30M | 26.10M | 14.00M |
| Income Tax Expenses | -15.90M | -14.90M | -17.00M | 4.40M | 7.00M |
| Earnings from Continuing Operations | -461.30 | -380.20 | -386.30 | 21.70 | 7.00 |
| Earnings from Discontinued Operations | -1.90M | -4.40M | -5.80M | -6.00M | 700.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -463.20M | -384.60M | -392.10M | 15.70M | 7.70M |
| EBIT | 38.10M | 41.90M | 36.60M | 44.80M | 42.90M |
| EBITDA | 80.50M | 85.60M | 82.10M | 90.70M | 85.50M |
| EPS Basic | -10.06 | -8.36 | -8.52 | 0.34 | 0.17 |
| Normalized Basic EPS | 0.43 | 0.50 | 0.40 | 0.51 | 0.46 |
| EPS Diluted | -10.07 | -8.38 | -8.54 | 0.33 | 0.16 |
| Normalized Diluted EPS | 0.42 | 0.49 | 0.40 | 0.50 | 0.46 |
| Average Basic Shares Outstanding | 184.40M | 184.00M | 184.10M | 184.30M | 185.10M |
| Average Diluted Shares Outstanding | 185.70M | 185.70M | 185.60M | 186.20M | 186.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |